1. Home
  2. IH vs ANVS Comparison

IH vs ANVS Comparison

Compare IH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.23

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

N/A

Current Price

$1.44

Market Cap

76.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IH
ANVS
Founded
1996
2008
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.5M
76.6M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
IH
ANVS
Price
$1.23
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
9.4K
529.8K
Earning Date
03-31-2026
05-12-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
39.39
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$1.54
52 Week High
$3.16
$5.50

Technical Indicators

Market Signals
Indicator
IH
ANVS
Relative Strength Index (RSI) 45.52 30.28
Support Level N/A N/A
Resistance Level $1.42 $2.02
Average True Range (ATR) 0.07 0.10
MACD 0.00 -0.03
Stochastic Oscillator 11.11 10.18

Price Performance

Historical Comparison
IH
ANVS

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: